KRAS and neoplasm: Moreover, exogenous IL-33 mimicked the effects observed in case of injury and cooperated with KRAS mutation to activate the neoplasia-specific and BRD4-dependent gene expression program, associated with an accelerated appearance of pancreatic intraepithelial neoplasia.